project id: TCGA-HNSC; case submitter id: TCGA-CN-A497; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.67; rna integrity number: 9.0; age at index: 63; days to birth: -23310; ethnicity: not hispanic or latino; gender: male; race: not reported; vital status: Alive; year of birth: 1948; age at diagnosis: 23310; ajcc clinical m: M0; ajcc clinical n: N2c; ajcc clinical stage: Stage IVA; ajcc clinical t: T2; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic stage: Stage III; ajcc pathologic t: T1; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1065.0; icd 10 code: C32.9; last known disease status: not reported; morphology: 8072/3; primary diagnosis: Squamous cell carcinoma, large cell, nonkeratinizing, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Larynx, NOS; synchronous malignancy: No; tissue or organ of origin: Larynx, NOS; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: No; is ffpe: false; composition: Not Reported; days to collection: 450; initial weight: 180.0; oct embedded: false; preservation method: Unknown; sample id: bea32bd5-4068-4351-994e-09b3bf819ebb; sample submitter id: TCGA-CN-A497-01A; portion id: bff2a320-c377-47dd-a3a7-d9fc03c486d9; portion submitter id: TCGA-CN-A497-01A-11; slide id: 1d32a485-5870-4978-bd07-0c2470583a32; slide submitter id: TCGA-CN-A497-01A-01-TSA; percent lymphocyte infiltration: 30.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 15.0; percent stromal cells: 5.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0; section location: TOP;